Advances in treating glioblastoma

Por Weathers, Shiao-Pei, Gilbert, Mark R.
Publicado em 2014

Toward Personalized Targeted Therapeutics: An Overview

Por Weathers, Shiao-Pei S., Gilbert, Mark R.
Publicado no Neurotherapeutics (2016)

Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases?

Por Majd, Nazanin, Weathers, Shiao-Pei, de Groot, John
Publicado no Neuro Oncol (2019)

Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson Disease

Por Weathers, Shiao-Pei S., Kotagal, Vikas, Bohnen, Nicolaas I., Chou, Kelvin L.
Publicado em 2013

ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma

Por Gatson, Na Tosha N, Weathers, Shiao-Pei S, de Groot, John F
Publicado no CNS Oncol (2016)

CMET-34. IMPROVEMENT OF LEPTOMENINGEAL DISEASE FOLLOWING INFECTIOUS MENINGITIS

Por Metrus, Nicholas, Kamiya, Carolos, Weathers, Shiao-Pei, Seligman, Christa, O’Brien, Barbara
Publicado no Neuro Oncol (2019)

Potential neurologic and oncologic implications of the novel coronavirus

Por Aaroe, Ashley Elimar, Majd, Nazanin, Weathers, Shiao-Pei, de Groot, John Frederick
Publicado no Neuro Oncol (2020)

QLIF-10. ILLNESS COMMUNICATION, SPOUSAL SUPPORT AND SYMPTOM BURDEN IN COUPLES COPING WITH GLIOMA

Por Milbury, Kathrin, Lopez, Gabriel, Weathers, Shiao-Pei, Eto, Obumneke, Li, Jing, Cohen, Lorenzo
Publicado no Neuro Oncol (2017)

EPT-17 PHASE I STUDY OF BRAF INHIBITOR (VEMURAFENIB) IN COMBINATION WITH THE MTOR INHIBITOR (EVEROLIMUS) IN BRAF(V600E) POSITIVE CHILDHOOD AND AYA BRAIN TUMORS

Por Tanaka, Ryuma, Khatua, Soumen, Zaky, Wafik, Penas-Prado, Marta, Weathers, Shiao-Pei, Subbiah, Vivek
Publicado no Neuro Oncol (2016)

SCDT-22. ROLE FOR LASER INTERSTITIAL THERMAL THERAPY (LITT) TO MANAGE PROGRESSED GLIOBLASTOMA DURING PREGNANCY

Por Gatson, Na Tosha, Brimley, Cameron, Rao, Ganesh, Chi, T Linda, Prabhu, Sujit, Weathers, Shiao-Pei
Publicado no Neuro Oncol (2017)

QLIF-21. FEASIBILITY RANDOMIZED CONTROLLED TRIAL OF A DYADIC YOGA PROGRAM FOR PATIENTS WITH BRAIN TUMORS UNDERGOING RADIOTHERAPY AND THEIR FAMILY CAREGIVERS

Por Milbury, Kathrin, Mallaiah, Smitha, Mahajan, Anita, Armstrong, Terri S, Weathers, Shiao-Pei, Li, Jing, Cohen, Lorenzo
Publicado no Neuro Oncol (2017)

A research protocol for a pilot, randomized controlled trial designed to examine the feasibility of a dyadic versus individual yoga program for family caregivers of glioma patients...

Por Milbury, Kathrin, Li, Jing, Weathers, Shiao-Pei, Shih, Tina, Malliaha, Smitha, Li, Yisheng, Cohen, Lorenzo
Publicado no Pilot Feasibility Stud (2019)

Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers

Por Milbury, Kathrin, Li, Jing, Weathers, Shiao-Pei, Mallaiah, Smitha, Armstrong, Terri, Li, Yisheng, Bruera, Eduardo, Cohen, Lorenzo
Publicado no Neurooncol Pract (2019)

Tumor Vaccines for Malignant Gliomas

Por Srinivasan, Visish M., Ferguson, Sherise D., Lee, Sungho, Weathers, Shiao-Pei, Kerrigan, Brittany C. Parker, Heimberger, Amy B.
Publicado no Neurotherapeutics (2017)

Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews

Por Acquaye, Alvina A., Payén, Samuel S., Vera, Elizabeth, Williams, Loretta A., Gilbert, Mark R., Weathers, Shiao-Pei, Armstrong, Terri S.
Publicado no J Patient Rep Outcomes (2019)

Pre-surgical connectome features predict IDH status in diffuse gliomas

Por Kesler, Shelli R., Harrison, Rebecca A., Petersen, Melissa L., Rao, Vikram, Dyson, Hannah, Alfaro-Munoz, Kristin, Weathers, Shiao-Pei, de Groot, John
Publicado no Oncotarget (2019)

Dual inhibition of BRAF and mTOR in BRAF(V600E)-mutant pediatric, adolescent, and young adult brain tumors

Por Sen, Shiraj, Tanaka, Ryuma, Khatua, Soumen, Zaky, Wafik, Janku, Filip, Penas-Prado, Marta, Weathers, Shiao-Pei, Behrang, Amini, Roszik, Jason, Subbiah, Vivek
Publicado no Cold Spring Harb Mol Case Stud (2020)

Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2

Por Wang, Michael, Jain, Preetesh, Chi, T Linda, Chen, Sheree E, Heimberger, Amy, Weathers, Shiao-Pei, Zheng, Lianqing, Rao, Arati V, Rossi, John M
Publicado no J Immunother Cancer (2020)

QOLP-11. QUALITY OF END-OF-LIFE CARE IN PATIENTS WITH HIGH GRADE GLIOMAS

Por Ou, Alexander, Harrison, Rebecca, Liu, Diane, Naqvi, Mujtaba, Naqvi, Syed Mussadiq, O’Brien, Barbara, Weathers, Shiao-Pei, de Groot, John, Bruera, Eduardo
Publicado no Neuro Oncol (2020)

Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor

Por Joseph, Jocelyn, Nathenson, Michael J., Trinh, Van Anh, Malik, Karan, Nowell, Erica, Carter, Kristen, Weathers, Shiao-Pei, Demetri, George D., Araujo, Dejka, Conley, Anthony P.
Publicado no J Immunother Cancer (2019)